Article révisé par les pairs
Titre:
  • No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.
Auteur:Lynch, John M; Tate, Sarah K; Kinirons, Peter; Weale, Michael E; Cavalleri, Gianpiero L; Depondt, Chantal; Murphy, Kevin; O'Rourke, Deirdre; Doherty, Colin P; Shianna, Kevin V; Wood, Nicholas W; Sander, Josemir W; Delanty, Norman; Goldstein, David B; Sisodiya, Sanjay M
Informations sur la publication:Epilepsy research, 83, 1, page (44-51)
Statut de publication:Publié, 2009-01
Sujet CREF:Neurologie
Mots-clés:Antiepileptic drugs
Association studies in genetics
Levetiracetam
Pharmacogenetics
Synaptic vesicle 2A
MeSH keywords:Adult
Anticonvulsants -- therapeutic use
Cohort Studies
Epilepsy -- drug therapy -- genetics
Epilepsy, Temporal Lobe -- drug therapy -- genetics
Female
Genetic Predisposition to Disease
Genetic Variation
Genotype
Great Britain
Hippocampus -- pathology
Humans
Ireland
Male
Membrane Glycoproteins -- genetics
Nerve Tissue Proteins -- genetics
Piracetam -- analogs & derivatives -- therapeutic use
Polymorphism, Genetic -- genetics
Synaptic Vesicles -- genetics
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0920-1211
info:doi/10.1016/j.eplepsyres.2008.09.003
info:pii/S0920-1211(08)00259-3
info:scp/57849143713
info:pmid/18977120

Documents en relation

DI-fusion